4th Quarter - Report
MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Pharmacy PHA
Meetings/education regarding pharmacy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Taxation/Internal Revenue Code TAX
Legislation regarding potential LIFO issue.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Health Issues HCR
Meetings/education regarding health care reform implementation and related issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Veterans VET
Education regarding the Department of Veterans Affairs Pharmaceutical Prime Vendor contract.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANN RICHARDSON BERKEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.